

Critical Mass CBD (Dinafem), 3, 5 or 10 feminised seeds
- Genetics: Critical Mass x CBD Crew
- feminised
- 80% Indica, 20% Sativa
- Flowering time indoor: 55 days
- Yield Indoor: 600 g/m²
- Yield outdoor: 700-1200 per plant
- Harvest outdoor: beginning of October
- Height outdoor: 3 m
- THC: 5%
- CBD: 5%
- THC:CBD: 1:1
Critical Mass CBD by Dinafem and CBD Crew: fast medicinal strain with a THC-CBD ratio of 1:1.
Critical Mass CBD is a joint project between Dinafem and the CBD Crew. The goal was to create a medicinal cannabis strain with a THc-CBD ratio of 1:1. Critical Mass CBD succeeds in this, as it has 5% THC and 5% CBD.
It is indica dominant, but grows like a sativa and stretches enormously during the flowering phase. The flowering time, however, is characterised by the indica genetics, so that it is ready for harvest indoors already after 55 days of flowering. It produces 600 g/m² of very firm, dense buds. Outdoors, it can be harvested at the beginning of October and surprises with more than 700 g per plant. It grows to medium height and is very resistant to parasites and fungi.
The smell and taste are sweetish with a touch of pine and pine. The effect pleasantly relaxing and unwinding without being unable to do anything more. The high CBD content is evident here, which is the medicinal benefit of this new strain.
Critical Mass CBD is Dinafem's best outdoor medicinal strain, used in the therapeutic field for inflammation, muscle tension, depressive disorders, stress, pain and arthristis, among others.
Pack size |
10 feminised seeds ,3 feminised seeds ,5 feminised seeds |
---|
Du musst angemeldet sein, um eine Bewertung abgeben zu können.
Similar products

Devil Fruit (Medical Seeds) feminised seeds
21,00 € - – 70,00 € incl. VAT
Jack La Mota (Medical Seeds) feminised seeds
29,00 € - – 95,00 € incl. VAT
Kali Mist (Serious Seeds) feminised or regular

Malakoff (Medical Seeds) feminised
26,00 € - – 85,00 € incl. VAT
No Name (Medical Seeds) feminised seeds
24,00 € - – 80,00 € incl. VAT
Reviews
There are no reviews yet.